Royce & Associates LP Cytosorbents Corp Transaction History

Royce & Associates LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	BUY	$2.88 - $4.23 $282,240 - $414,540	98,000 Added 39.04%	349,000 $1.11 Million
Q4 2021 Feb 07, 2022	BUY	$4.05 - $8.11 $222,750 - $446,049	55,000 Added 28.06%	251,000 $1.05 Million
Q3 2021 Nov 10, 2021	BUY	$7.0 - $9.71 $413,000 - $572,890	59,000 Added 43.07%	196,000 $1.59 Million
Q3 2020 Nov 12, 2020	BUY	$7.37 - $11.54 $147,400 - $230,799	20,000 Added 17.09%	137,000 $1.09 Million
Q2 2020 Aug 07, 2020	BUY	$6.28 - $10.59 $337,160 - $568,555	53,688 Added 84.8%	117,000 $1.16 Million
Q1 2020 May 12, 2020	BUY	$3.77 - $7.73 $238,686 - $489,401	63,312 New	63,312 $489,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.